Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic HBV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04749368
Recruitment Status : Recruiting
First Posted : February 11, 2021
Last Update Posted : November 4, 2021
Vir Biotechnology, Inc.
VBI Vaccines Inc.
Information provided by (Responsible Party):
Brii Biosciences Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : July 2023